{"meta":{"query_hash":"f0a14815ad60","filters":{"venue":"The EPMA Journal"},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f0a14815ad60","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+EPMA+Journal"},"results":[{"id":"W2032838748","doi":"10.1007/s13167-011-0103-0","title":"Forms of antipsychotic therapy: improved individual outcomes under personalised treatment of schizophrenia focused on depression","year":2011,"lang":"en","type":"article","venue":"The EPMA Journal","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schizophrenia (object-oriented programming); Psychiatry; Risperidone; Olanzapine; Quetiapine; Antipsychotic; Context (archaeology); Psychology; Clozapine; Brief Psychiatric Rating Scale; Depression (economics); Antidepressant; Atypical antipsychotic; Psychosocial; Clinical psychology; Medicine; Psychosis; Anxiety","score_opus":0.0951688856932852,"score_gpt":0.3239588257492911,"score_spread":0.2287899400560059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032838748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995933,0.0009530476,0.00013798506,0.0001737264,0.000014812779,0.000040736642,0.00021011796,0.000025359073,0.0025112394],"genre_scores_gemma":[0.9982254,0.00057574507,0.00030620795,0.00006419348,0.000019184008,0.000020240026,0.00021141095,0.000003047074,0.0005745962],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997522,0.00007498688,0.000033436536,0.000034265093,0.000055935237,0.00004914627],"domain_scores_gemma":[0.9994772,0.00005460515,0.00025561464,0.000048641075,0.000036557656,0.0001274595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049040955,0.00016320709,0.0003862287,0.00022962097,0.00019724386,0.00029578645,0.00014281183,0.00020586132,0.0018340931],"category_scores_gemma":[0.0012601562,0.000069018955,0.0003564857,0.00032838635,0.00012268008,0.00032763864,0.00035311797,0.00033560855,0.00026216582],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029047146,0.0050383755,0.2322107,0.0003752229,0.0008522277,0.00026706536,0.00051239034,0.0022219724,0.0049425173,0.00043743345,0.0015613794,0.7225336],"study_design_scores_gemma":[0.0008132134,0.007930855,0.9868411,0.00005383762,0.00026233794,0.00038160442,0.00010369894,0.00078292977,0.0005631388,0.0005881529,0.0016619123,0.000017229557],"about_ca_topic_score_codex":0.0009107782,"about_ca_topic_score_gemma":0.0026935593,"teacher_disagreement_score":0.0018340931,"about_ca_system_score_codex":0.00043334244,"about_ca_system_score_gemma":0.00030275513,"threshold_uncertainty_score":0.0061356425},"labels":[],"label_agreement":null},{"id":"W2093051327","doi":"10.1007/s13167-010-0019-0","title":"New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatment","year":2010,"lang":"en","type":"article","venue":"The EPMA Journal","topic":"Neurological diseases and metabolism","field":"Neuroscience","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Prince Edward Island","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Neurodegeneration; Disease; Medicine; Intensive care medicine; Intervention (counseling); Psychological intervention; Animal model; Neuroscience; Pathology; Psychology; Psychiatry; Internal medicine","score_opus":0.07536354864073715,"score_gpt":0.3180265740089024,"score_spread":0.24266302536816525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093051327","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18435682,0.3934146,0.35240927,0.016788946,0.004705126,0.0032803593,0.0048489417,0.0030563683,0.037139475],"genre_scores_gemma":[0.26887843,0.42164102,0.27716222,0.0033078385,0.0010458503,0.004640515,0.004807582,0.00033701517,0.018179547],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99931836,0.00025547948,0.00007417681,0.000091131806,0.00019417772,0.00006664008],"domain_scores_gemma":[0.99919313,0.0002847163,0.00016461044,0.00013300107,0.000106551044,0.00011789695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002344691,0.0013412724,0.0016755037,0.0018402325,0.00052059145,0.0014564423,0.0015991939,0.0022141617,0.0033244814],"category_scores_gemma":[0.0009973239,0.00060389494,0.0008157565,0.00065920927,0.0012347879,0.0020042553,0.0008692204,0.0041543734,0.0012567742],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017030642,0.0017182027,0.0013529579,0.0030058795,0.00022737558,0.0011327367,0.00022666567,0.0010600274,0.85829526,0.020512387,0.009796188,0.100969285],"study_design_scores_gemma":[0.0014540482,0.019961491,0.010232488,0.002650205,0.001705848,0.0094192,0.0005961281,0.0073613226,0.54025686,0.028778063,0.37725142,0.00033285635],"about_ca_topic_score_codex":0.00071878737,"about_ca_topic_score_gemma":0.0018308363,"teacher_disagreement_score":0.0033244814,"about_ca_system_score_codex":0.0008322789,"about_ca_system_score_gemma":0.0007367521,"threshold_uncertainty_score":0.012400091},"labels":[],"label_agreement":null},{"id":"W2132365023","doi":"10.1007/s13167-011-0138-2","title":"Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon?","year":2012,"lang":"en","type":"article","venue":"The EPMA Journal","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Prostate cancer; Medicine; Cabazitaxel; Taxane; Oncology; Androgen deprivation therapy; Cancer; Malignancy; Androgen receptor; Enzalutamide; Internal medicine; Disease; Abiraterone acetate; Breast cancer","score_opus":0.0768418533837116,"score_gpt":0.41243847778124265,"score_spread":0.335596624397531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132365023","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020754332,0.69134766,0.06319573,0.2020362,0.00382578,0.00056501746,0.00061807584,0.00054028886,0.017116891],"genre_scores_gemma":[0.2666121,0.51953226,0.1284612,0.067551285,0.010007084,0.0011217172,0.0009796002,0.0002443551,0.0054903473],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99004996,0.0060876883,0.0007936431,0.0007675176,0.0019457438,0.0003555827],"domain_scores_gemma":[0.9761144,0.014585055,0.003348367,0.0015133412,0.0032963639,0.001142435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030253755,0.0013024483,0.0048777084,0.0011311851,0.00060548045,0.005900014,0.0016685582,0.0030232512,0.0062889243],"category_scores_gemma":[0.032795373,0.0005592139,0.001351283,0.0017110362,0.0028192797,0.008179767,0.0018289237,0.0056778253,0.0017668229],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021300125,0.00073262246,0.011577767,0.0022283737,0.00052064937,0.00015427898,0.00017371513,0.0018745736,0.0025796895,0.026641674,0.016906155,0.9344805],"study_design_scores_gemma":[0.0026120925,0.0180368,0.05546445,0.014108276,0.0028815204,0.0029114443,0.0019882491,0.009432995,0.011276344,0.26582274,0.61467403,0.0007910598],"about_ca_topic_score_codex":0.00078270596,"about_ca_topic_score_gemma":0.0010948094,"teacher_disagreement_score":0.030253755,"about_ca_system_score_codex":0.0019847436,"about_ca_system_score_gemma":0.004715332,"threshold_uncertainty_score":0.15999907},"labels":[],"label_agreement":null},{"id":"W2752602007","doi":"10.1007/s13167-017-0114-6","title":"The BSSG rat model of Parkinson’s disease: progressing towards a valid, predictive model of disease","year":2017,"lang":"en","type":"review","venue":"The EPMA Journal","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Prince Edward Island","funders":"Canadian Institutes of Health Research; Weston Brain Institute","keywords":"Neuropathology; Neuroscience; Dopaminergic; Dopamine; MPTP; Parkinson's disease; Neuroprotection; Disease; Levodopa; Medicine; Oxidopamine; Psychology; Substantia nigra; Pathology","score_opus":0.14365012580086206,"score_gpt":0.38964753527632995,"score_spread":0.2459974094754679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752602007","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8343174,0.035764888,0.092021674,0.008785789,0.0023718814,0.0010605996,0.008053706,0.0032908088,0.014333288],"genre_scores_gemma":[0.82895356,0.035846762,0.0916325,0.00202114,0.00069063675,0.0015638698,0.013552151,0.00070121104,0.02503816],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9988607,0.00024361559,0.00012515417,0.0001990353,0.0004409109,0.00013056428],"domain_scores_gemma":[0.99881965,0.0001164713,0.00023251124,0.00027731387,0.00027319448,0.000280907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022993104,0.0022487137,0.0011972311,0.002662942,0.0007354506,0.0012861895,0.0017553011,0.0017223655,0.0025905864],"category_scores_gemma":[0.0006538455,0.0004627264,0.00091417326,0.00091905176,0.0016621589,0.0018833472,0.0009084797,0.003723518,0.0013466022],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002169146,0.0022903667,0.0027068956,0.00073752255,0.00014487235,0.000831142,0.00025923882,0.0009225246,0.9400469,0.00887802,0.0041986764,0.036814608],"study_design_scores_gemma":[0.0014445679,0.024928775,0.021184225,0.0011804339,0.0013227699,0.009105022,0.0005719458,0.015895575,0.77076226,0.014134495,0.13908099,0.00038891257],"about_ca_topic_score_codex":0.0020030034,"about_ca_topic_score_gemma":0.0029395504,"teacher_disagreement_score":0.002662942,"about_ca_system_score_codex":0.0013083508,"about_ca_system_score_gemma":0.00139103,"threshold_uncertainty_score":0.012160063},"labels":[],"label_agreement":null},{"id":"W2753271743","doi":"10.1007/s13167-017-0111-9","title":"Progressive changes in hippocampal cytoarchitecture in a neurodevelopmental rat model of epilepsy: implications for understanding presymptomatic epileptogenesis, predictive diagnosis, and targeted treatments","year":2017,"lang":"en","type":"article","venue":"The EPMA Journal","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Prince Edward Island","funders":"Natural Sciences and Engineering Research Council of Canada; Atlantic Canada Opportunities Agency","keywords":"Epileptogenesis; NeuN; Epilepsy; Hippocampal formation; Astrogliosis; Medicine; Glial fibrillary acidic protein; Gliosis; Kindling; Neuroscience; Hippocampus; Population; Pathology; Internal medicine; Biology; Central nervous system; Immunohistochemistry; Psychiatry","score_opus":0.1387671134989877,"score_gpt":0.37487238703185977,"score_spread":0.23610527353287206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753271743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957468,0.0011329377,0.0017352868,0.00016908975,0.000021923144,0.000053322063,0.000403682,0.000094675604,0.00064215384],"genre_scores_gemma":[0.98919314,0.0026353346,0.0040102014,0.000101191246,0.000011845848,0.000114544586,0.0006825532,0.00002136413,0.003229845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990416,0.0000085708025,0.0000091158145,0.000024315887,0.000027696615,0.000026263473],"domain_scores_gemma":[0.9998197,0.000012975145,0.000078330035,0.000022356078,0.000018223282,0.000048433994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018011952,0.0007189329,0.0003653261,0.00084671495,0.00017595499,0.00023819853,0.00037309964,0.00031638923,0.00097457157],"category_scores_gemma":[0.00009508865,0.00016266985,0.0002461859,0.00017809273,0.0005445744,0.00038591312,0.00022350712,0.0008745906,0.0002371136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035455253,0.00018782508,0.001398723,0.000039814004,0.000008026325,0.00022096468,0.000035823257,0.00009431737,0.9947273,0.0001236825,0.00004378989,0.0027650683],"study_design_scores_gemma":[0.00007484513,0.00477404,0.048591305,0.000035302382,0.000063074745,0.0013211406,0.00021817735,0.0009834564,0.9419341,0.00027740953,0.0017074505,0.000019581617],"about_ca_topic_score_codex":0.0020850007,"about_ca_topic_score_gemma":0.0053871986,"teacher_disagreement_score":0.0020850007,"about_ca_system_score_codex":0.000554393,"about_ca_system_score_gemma":0.00051713444,"threshold_uncertainty_score":0.004145801},"labels":[],"label_agreement":null},{"id":"W4388498231","doi":"10.1007/s13167-023-00344-2","title":"Conceptualised psycho-medical footprint for health status outcomes and the potential impacts for early detection and prevention of chronic diseases in the context of 3P medicine","year":2023,"lang":"en","type":"article","venue":"The EPMA Journal","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Edith Cowan University","keywords":"Subclinical infection; Medicine; Context (archaeology); Population; Relevance (law); Environmental health; Pathology","score_opus":0.024119285234545648,"score_gpt":0.36886311973822267,"score_spread":0.344743834503677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388498231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9316365,0.001330924,0.03056092,0.009151552,0.000066996974,0.00008132481,0.00048033864,0.00005228668,0.026639113],"genre_scores_gemma":[0.99592614,0.00017743262,0.0033356003,0.0001532092,0.000013105584,0.00002071791,0.000072528914,0.000005169711,0.00029619367],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99944526,0.0003556615,0.000014664134,0.00007126532,0.00006746537,0.00004575269],"domain_scores_gemma":[0.9982828,0.00085921213,0.00034858173,0.00013138782,0.00014140866,0.00023673364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015169004,0.00023280355,0.00013479288,0.0013643152,0.000651208,0.0019468257,0.00043614622,0.00046281132,0.00413073],"category_scores_gemma":[0.004988126,0.00013712328,0.00033852423,0.00093030103,0.0026124164,0.0017051372,0.0015790354,0.00086790125,0.00017308489],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019674703,0.00023780306,0.67165416,0.00035206033,0.00018351433,0.0007614322,0.03725797,0.0062885867,0.0027309745,0.16676603,0.0032862595,0.110284425],"study_design_scores_gemma":[0.000015880598,0.00021137611,0.80299455,0.0003179788,0.00008251747,0.0010620583,0.029511342,0.020974556,0.0003899071,0.12739946,0.016989158,0.00005122141],"about_ca_topic_score_codex":0.004382027,"about_ca_topic_score_gemma":0.0065526916,"teacher_disagreement_score":0.004382027,"about_ca_system_score_codex":0.0015079647,"about_ca_system_score_gemma":0.0007815076,"threshold_uncertainty_score":0.013818622},"labels":[],"label_agreement":null},{"id":"W4399105668","doi":"10.1007/s13167-024-00368-2","title":"Unraveling progression subtypes in people with Huntington’s disease","year":2024,"lang":"en","type":"article","venue":"The EPMA Journal","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"CHDI Foundation","keywords":"Disease; Huntington's disease; Cognition; Trinucleotide repeat expansion; Movement disorders; Medicine; Cluster (spacecraft); Psychology; Clinical psychology; Psychiatry; Internal medicine; Genetics; Gene; Allele; Biology","score_opus":0.019403174496352232,"score_gpt":0.28563002957332007,"score_spread":0.26622685507696786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399105668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97764665,0.0025058019,0.008998637,0.00058969634,0.000051539282,0.000081467115,0.008302588,0.000090802656,0.0017328116],"genre_scores_gemma":[0.9854616,0.0006014524,0.0055519873,0.00007620155,0.000037971982,0.000054716173,0.0076174964,0.000018306746,0.00058038573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997534,0.000062147636,0.000028450984,0.00009094552,0.00003055147,0.000034452165],"domain_scores_gemma":[0.99957544,0.00011595917,0.00010138997,0.00005203473,0.00010272168,0.000052478965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000754254,0.00038118163,0.0003922328,0.0011803022,0.0003153936,0.0006663952,0.00039053758,0.00038936138,0.0011597046],"category_scores_gemma":[0.0020929398,0.00013578868,0.0005459074,0.0007906782,0.00012717988,0.0005759477,0.0006761305,0.0007224525,0.00031194923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045287478,0.00011736314,0.9059,0.00021527075,0.0002536623,0.00026946387,0.00079208676,0.0036511628,0.0012856101,0.00065029855,0.0038037011,0.08260847],"study_design_scores_gemma":[0.00004023488,0.00025607907,0.9120826,0.0002952288,0.00032129267,0.00075004855,0.0014249474,0.07093835,0.00075566676,0.0059693595,0.0071251793,0.000040945655],"about_ca_topic_score_codex":0.01926162,"about_ca_topic_score_gemma":0.040968224,"teacher_disagreement_score":0.01926162,"about_ca_system_score_codex":0.00040774918,"about_ca_system_score_gemma":0.00048734376,"threshold_uncertainty_score":0.038299024},"labels":[],"label_agreement":null},{"id":"W4403952995","doi":"10.1007/s13167-024-00381-5","title":"3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation","year":2024,"lang":"en","type":"article","venue":"The EPMA Journal","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Liver transplantation; Liver disease; Intensive care unit; Alcoholic hepatitis; Propensity score matching; Hepatitis; Alcoholic liver disease; Cirrhosis","score_opus":0.11357070699810307,"score_gpt":0.39797554732921153,"score_spread":0.28440484033110847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403952995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641737,0.015417511,0.0105143655,0.0027864997,0.0005346748,0.0015220055,0.000743839,0.00009762043,0.0042097326],"genre_scores_gemma":[0.9900239,0.002174074,0.004949793,0.00078510895,0.00024509188,0.00091349933,0.0003000166,0.000008815263,0.00059982244],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806064,0.001303057,0.0001549652,0.0001360597,0.00016116322,0.00018406822],"domain_scores_gemma":[0.99860233,0.00036000882,0.00048726567,0.0001465426,0.00014071539,0.00026317342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002558502,0.00026821037,0.0007022092,0.00038046314,0.00031197272,0.00074309926,0.00032648933,0.00041748228,0.0034033642],"category_scores_gemma":[0.0035269326,0.000093694696,0.0010479854,0.00044452737,0.00050983374,0.00045413448,0.0008972039,0.00069075247,0.00033013386],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.063519716,0.012096016,0.23477426,0.0061355093,0.0026642047,0.0008495956,0.000744811,0.009030966,0.011885029,0.00510268,0.0058530173,0.6473442],"study_design_scores_gemma":[0.022995524,0.18146776,0.6268211,0.0041566836,0.0060121464,0.0026965868,0.002031953,0.03685487,0.02039653,0.019188799,0.07714599,0.00023207699],"about_ca_topic_score_codex":0.0006137421,"about_ca_topic_score_gemma":0.0011569248,"teacher_disagreement_score":0.0034033642,"about_ca_system_score_codex":0.00047723253,"about_ca_system_score_gemma":0.0016553759,"threshold_uncertainty_score":0.013530791},"labels":[],"label_agreement":null}]}